(Q54374929)

28 May 2018

title

Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma. (English)

1 reference

28 May 2018

author

Eduardo Nagore

2

1 reference

28 May 2018

Rajiv Kumar

10

1 reference

28 May 2018

Kari Hemminki

9

object named as

Kari Hemminki

1 reference

28 May 2018

7

Jürgen Becker

1 reference

28 May 2018

author name string

Barbara Heidenreich

1

1 reference

28 May 2018

P Sivaramakrishna Rachakonda

3

1 reference

28 May 2018

Zaida Garcia-Casado

4

1 reference

28 May 2018

Celia Requena

5

1 reference

28 May 2018

Victor Traves

6

1 reference

28 May 2018

Nadem Soufir

8

1 reference

28 May 2018

language of work or name

English

0 references

publication date

26 February 2014

1 reference

28 May 2018

published in

Nature Communications

1 reference

28 May 2018

volume

5

1 reference

28 May 2018

page(s)

3401

1 reference

28 May 2018

https://scigraph.springernature.com/pub.10.1038/ncomms4401

exact match

0 references

cites work

Why is melanoma so metastatic?

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

Signatures of mutational processes in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

A landscape of driver mutations in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

BRAF/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

Exome sequencing identifies GRIN2A as frequently mutated in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

TERT promoter mutations in familial and sporadic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

Highly recurrent TERT promoter mutations in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

Frequency of TERT promoter mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

TERT promoter mutations rather than methylation are the main mechanism for TERT upregulation in adult gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

TERT promoter mutations in cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

JASPAR, the open access database of transcription factor-binding profiles: new content and tools in the 2008 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

Telomerase maintains telomere structure in normal human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

Telomere rejuvenation during nuclear reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

Telomerase: central regulator of all of the hallmarks of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

21 January 2018

Telomerase and cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

Comprehensive mutation analysis of the TERT promoter in bladder cancer and detection of mutations in voided urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

Determinants of BRAF mutations in primary melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

Novel morphological study of solar lentigines by immunohistochemical and electron microscopic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

Prognostic importance of the extent of ulceration in patients with clinically localized cutaneous melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

Outcomes and prognostic factors in superficial spreading melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

Changes in the presentation of nodular and superficial spreading melanomas over 35 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

Genes and pathways downstream of telomerase in melanoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

BRAF mutations are common somatic events in melanocytic nevi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

BRAF(E600) in benign and malignant human tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

Telomere biology and translational research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

Novel anticancer therapeutics targeting telomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

Resistance to BRAF-targeted therapy in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

Melanocortin receptor 1 variants and melanoma risk: a study of 2 European populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

NRAS and BRAF Mutations in Cutaneous Melanoma and the Association with MC1R Genotype: Findings from Spanish and Austrian Populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

7 January 2021

Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

7 January 2021

The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

7 January 2021

Suntan, sunburn, and pigmentation factors and the frequency of acquired melanocytic nevi in children. Similarities to melanoma: the Vancouver Mole Study

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4401

7 January 2021

Identifiers

DOI

10.1038/NCOMMS4401

1 reference

28 May 2018

release_dccknccy3fd6jkrncvnkxuwc64

ADS bibcode

2014NatCo...5.3401H

0 references

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dccknccy3fd6jkrncvnkxuwc64

24 November 2022

mapped directly with Wikidata item

PubMed ID

24569790

1 reference

28 May 2018